Chemoinformaics analysis of L-2,4-DIAMINOBUTYRIC ACID DIHYDROCHLORIDE
| Molecular Weight | 191.058 | nRot | 3 |
| Heavy Atom Molecular Weight | 178.962 | nRig | 1 |
| Exact Molecular Weight | 190.028 | nRing | 0 |
| Solubility: LogS | -0.402 | nHRing | 0 |
| Solubility: LogP | -3.783 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 22.8455 |
| nHD | 3 | BPOL | 12.7865 |
| QED | 0.432 |
| Synth | 2.724 |
| Natural Product Likeliness | 1.59 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.016 |
| HIA | 0.061 |
| CACO-2 | -6.347 |
| MDCK | 0.0100045 |
| BBB | 0.344 |
| PPB | 0.0844967 |
| VDSS | 0.674 |
| FU | 0.933006 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.137 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.247 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.028 |
| CL | 5.987 |
| T12 | 0.541 |
| hERG | 0.031 |
| Ames | 0.357 |
| ROA | 0.096 |
| SkinSen | 0.422 |
| Carcinogencity | 0.071 |
| EI | 0.091 |
| Respiratory | 0.211 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.956512 |